N/A
Completed N=14
Feasibility of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors
Fatigue · Sleep Disturbances · Circadian Dysregulation
Source: ClinicalTrials.gov NCT02954809 ↗
Enrolled (actual)
14
Serious AEs
0.0%
Results posted
May 2025
Primary outcomePrimary: Study Completion — 7; 5 Participants
Summary
The purpose of this study is to determine the feasibility of a morning bright light therapy intervention for fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Study Completion |
7; 5 | — |
Eligibility Criteria
Inclusion Criteria
- Stage I-III Non-small cell lung cancer survivors
- Must be at >6-weeks and < 3 years post-surgical resection
- Must have diagnosis fatigue and/or sleep disturbances
Exclusion Criteria
- Individuals clinically unstable.
- Mania, Bipolar disease or seizure disorder
- Macular degeneration or glaucoma.
- Currently receiving chemotherapy or radiation.
Data sourced from ClinicalTrials.gov (NCT02954809). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.